Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cen Xu

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Cephalalgia : an International Journal of Headache|July 10, 2019
Characterisation of vasodilatory responses in the presence of the CGRP receptor antibody erenumab in human isolated arteriesEloísa Rubio-Beltrán, Alejandro Labastida-Ramírez, Kristian A Haanes, et al.
Regulatory Toxicology and Pharmacology : RTP|May 16, 2019
Nonclinical safety evaluation of erenumab, a CGRP receptor inhibitor for the prevention of migraineJeanine L Bussiere, Rhian Davies, Charles Dean, et al.
Organic Letters|June 4, 2005
Stereoselective synthesis of new conformationally restricted analogues of a potent CGRP receptor antagonistDmitry Zuev, Jodi A Michne, Hong Huang, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2011
Chromenones as potent bradykinin B1 antagonistsMarian C Bryan, Kaustav Biswas, Tanya A N Peterkin, et al.
Reproductive Biology and Endocrinology : RB&E|August 20, 2024
Single-cell RNA sequencing reveals the effects of high-fat diet on oocyte and early embryo development in female miceQi Zhu, Feng Li, Hao Wang, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2013
Preparation of imidazoles as potent calcitonin gene-related peptide (CGRP) antagonistsGeorge Tora, Andrew P Degnan, Charles M Conway, et al.
Pain|March 7, 2020
PAC1 receptor blockade reduces central nociceptive activity: new approach for primary headache?Jan Hoffmann, Silke Miller, Margarida Martins-Oliveira, et al.
ACS Pharmacology & Translational Science|April 8, 2020
Discovery of the Migraine Prevention Therapeutic Aimovig (Erenumab), the First FDA-Approved Antibody against a G-Protein-Coupled ReceptorChadwick Terence King, Colin V Gegg, Sylvia Nai-Yu Hu, et al.
Cell Research|February 13, 2020
Cryo-EM structures of PAC1 receptor reveal ligand binding mechanismJia Wang, Xianqiang Song, Dandan Zhang, et al.
Cell Research|March 24, 2020
Author Correction: Cryo-EM structures of PAC1 receptor reveal ligand binding mechanismJia Wang, Xianqiang Song, Dandan Zhang, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Cephalalgia : an International Journal of Headache|July 10, 2019
Characterisation of vasodilatory responses in the presence of the CGRP receptor antibody erenumab in human isolated arteriesEloísa Rubio-Beltrán, Alejandro Labastida-Ramírez, Kristian A Haanes, et al.
Regulatory Toxicology and Pharmacology : RTP|May 16, 2019
Nonclinical safety evaluation of erenumab, a CGRP receptor inhibitor for the prevention of migraineJeanine L Bussiere, Rhian Davies, Charles Dean, et al.
Organic Letters|June 4, 2005
Stereoselective synthesis of new conformationally restricted analogues of a potent CGRP receptor antagonistDmitry Zuev, Jodi A Michne, Hong Huang, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2011
Chromenones as potent bradykinin B1 antagonistsMarian C Bryan, Kaustav Biswas, Tanya A N Peterkin, et al.
Reproductive Biology and Endocrinology : RB&E|August 20, 2024
Single-cell RNA sequencing reveals the effects of high-fat diet on oocyte and early embryo development in female miceQi Zhu, Feng Li, Hao Wang, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2013
Preparation of imidazoles as potent calcitonin gene-related peptide (CGRP) antagonistsGeorge Tora, Andrew P Degnan, Charles M Conway, et al.
Pain|March 7, 2020
PAC1 receptor blockade reduces central nociceptive activity: new approach for primary headache?Jan Hoffmann, Silke Miller, Margarida Martins-Oliveira, et al.
ACS Pharmacology & Translational Science|April 8, 2020
Discovery of the Migraine Prevention Therapeutic Aimovig (Erenumab), the First FDA-Approved Antibody against a G-Protein-Coupled ReceptorChadwick Terence King, Colin V Gegg, Sylvia Nai-Yu Hu, et al.
Cell Research|February 13, 2020
Cryo-EM structures of PAC1 receptor reveal ligand binding mechanismJia Wang, Xianqiang Song, Dandan Zhang, et al.
Cell Research|March 24, 2020
Author Correction: Cryo-EM structures of PAC1 receptor reveal ligand binding mechanismJia Wang, Xianqiang Song, Dandan Zhang, et al.
Pageof 7